Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period: A Comparison of Early and Late Manifestations in a Cohort of 1,000 Patients

By R. Cervera, M. Khamashta, J. Font, G. Sebastiani, A. Gil, P. Lavilla, J. Mejía, A. Aydintug, H. Chwalińska-Sadowska, E. de Ramón and 10 more. Medicine, 2003

1,346 citations recorded by the source corpus.

Subfields: Immunology, Pathology and Forensic Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/a108ebe0b38d0e3cfa96718359778c835733625a

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. B. Hahn
2. M. McMahon
3. A. Wilkinson
4. W. Wallace
5. M. Ramos-Casals
6. D. Daikh
7. G. Ruiz‐Irastorza
8. J. Fitzgerald

Citations in the corpus

• Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review (2008, background): “As a consequence, more than 50% of patients in many SLE cohorts have never been treated with AMs.”
• American College of Rheumatology Guidelines for Screening, Case Definition, Treatment and Management of Lupus Nephritis (2012, background): “Overall survival in patients with SLE is approximately 95% at 5 years after diagnosis and 92% at 10 years [5, 6].”